Detalhe da pesquisa
1.
Adherence and safety of regorafenib for patients with metastatic colorectal cancer: observational real-life study.
Future Oncol
; 13(5): 415-423, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27780365
2.
Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study.
Future Oncol
; 11(2): 219-24, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25078333
3.
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey.
Future Oncol
; 10(1): 69-78, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24328410
4.
Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave.
Eur J Cancer
; 148: 112-116, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743478
5.
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting.
Oncotarget
; 11(22): 2083-2091, 2020 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32547706
6.
A new case of radiation-induced breast angiosarcoma.
Int J Surg Case Rep
; 60: 152-155, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31228777
7.
Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.
Front Pharmacol
; 8: 484, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28775690
8.
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study.
Cancer Chemother Pharmacol
; 66(5): 837-44, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20041325
9.
Association between mode of breast cancer detection and diagnosis delay.
Breast
; 18(6): 382-6, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19879761